Tag Archives: NIAID

A Timely Reminder of Fauci's Call for a Transformative TB Research Agenda

By on .

What will come of Anthony Fauci’s call for a “transformative” research agenda for tuberculosis, in which doctors and scientists get new resources and support in the search for better drugs and diagnostics to combat this ancient scourge? Fauci, head of the National Institute of Allergy and Infectious Diseases, delivered that appeal for a more aggressive approach […]

TB, A Global Threat That Requires New Vision, Strong Leadership

By on .

During a live interactive webcast today hosted by the Kaiser Family Foundation, an expert panel agreed that tuberculosis poses a grave global health threat and demands an innovative, multifaceted response—from new drugs to scaled-up treatment to better infection control. The lively forum, available here, highlighted the need for an aggressive approach to the global tuberculosis […]

Live Webcast on Global TB Featuring Renowned South African Physician/Scientist

By on .

The Kaiser Family Foundation will hold a live, interactive webcast on Tuesday, Sept. 28, at 1 p.m. EDT on the threat of tuberculosis and the U.S. strategy for combating this ancient deadly disease. An expert panel is set to discuss this growing global health threat, including two of the U.S. government’s top infectious disease specialists […]

Calls for strengthened lab capacity, service delivery and better policy–while resource question looms large

By on .

Editor’s Note: This is another dispatch from the Pacific Health Summit, filed by Christine Lubinski, director of the Center for Global Health Policy. Following NIAID Director Anthony Fauci’s powerful call for a transformative research agenda for tuberculosis, other presenters highlighted the challenges in wooing pharmaceutical companies, biotech firms and young researchers to the field of […]

Fauci: New TB research agenda desperately needed

By on .

This live blog is from the Pacific Health Summit in Seattle, a three-day meeting that opened Tuesday night. Its focus is the global response to multidrug-resistant tuberculosis. Anthony Fauci, the longtime director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, told the Pacific Health Summit today that it […]

Earlier ART=Better Chance for Survival

By on .

In a significant development, the National Institute of Allergy and Infectious Diseases announced that it a trial in Haiti–investigating the impact of earlier ART therapy in HIV-positive patients—would be ended early because the results were overwhelming; the findings showed that HIV-infected adults are more likely to survive if they start antiretroviral drugs before their immune […]

More Stimulus Funding News

By on .

As we recently mentioned on this blog, the economic stimulus package included a decent chunk of money for new scientific research.   Here’s a bevy of links for interested scientists:   This first one is a broad overview of NIAID’s role in doling out some of the Economic Recovery Act money: http://www.niaid.nih.gov/ncn/recovery/ Now some more detailed funding […]